Dr. David Lawrence

Biography

David Lawrence is a Conjoint Lecturer at the University of New South Wales (UNSW) in the School of Clinical Medicine and a Research Officer/Levi Wheeler Fellow at the Children’s Cancer Institute (CCIA). His research focuses on developing combination therapies for pediatric brainstem tumors, primarily Diffuse Intrinsic Pontine Glioma (DIPG). David completed his Bachelor’s and Master’s degrees in Neuroscience and Human Biology at the University of Veterinary Medicine and Eotvos Lorand University in Budapest, Hungary. He was awarded a competitive Vice Chancellor’s PhD scholarship at the University of Newcastle (UON), where he contributed to anatomy teaching as a Casual Lecturer in the School of Biomedical Sciences and Pharmacy. David completed his PhD at UON in 2023, concentrating on the anatomy and physiology of the brainstem and the implications for novel therapy development for motion sickness and balance disorders. In 2024, he joined the Brain Tumours Group at CCIA as a postdoctoral researcher under the Levi’s Project. His research aims to develop novel combination therapies using the small-molecule brain penetrant drug ACT001, employing in vitro molecular techniques, high-throughput combination drug screening, proteomics, RNA sequencing, and patient-derived xenograft animal models to provide effective treatments for DIPG.

Research Interests

Experience